MAb U36, a novel monoclonal antibody successful in immunotargeting of squamous cell carcinoma of the head and neck. (Q39113030)

From Wikidata
Jump to navigation Jump to search
scientific article published on September 1993
edit
Language Label Description Also known as
English
MAb U36, a novel monoclonal antibody successful in immunotargeting of squamous cell carcinoma of the head and neck.
scientific article published on September 1993

    Statements

    MAb U36, a novel monoclonal antibody successful in immunotargeting of squamous cell carcinoma of the head and neck (English)

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit